PruGen Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- PruGen Pharmaceuticals's estimated annual revenue is currently $4.8M per year.
- PruGen Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- PruGen Pharmaceuticals has 24 Employees.
- PruGen Pharmaceuticals grew their employee count by 4% last year.
PruGen Pharmaceuticals's People
Name | Title | Email/Phone |
---|
PruGen Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.3M | 111 | 8% | N/A | N/A |
#2 | $17.7M | 88 | -19% | N/A | N/A |
#3 | $6.6M | 33 | -8% | N/A | N/A |
#4 | $29.1M | 145 | 48% | N/A | N/A |
#5 | $1.2M | 6 | -50% | N/A | N/A |
#6 | $2.2M | 11 | 10% | N/A | N/A |
#7 | $4.8M | 24 | -17% | N/A | N/A |
#8 | $34.8M | 173 | 5% | N/A | N/A |
#9 | $46.2M | 230 | 5% | N/A | N/A |
#10 | $3.2M | 16 | -11% | N/A | N/A |
What Is PruGen Pharmaceuticals?
Our Mission is to provide high quality products, exclusively to specialists, that meet the real needs of patients while offering easy access and great value in treating skin care conditions. Our commitment is not only to provide the highest quality products, but also to make sure patients have convenient access and affordable pricing for the treatment of their condition. Our heritage and our values are at the foundation of our company and while we offer innovative and cost-effective products we also focus on our delivery of excellent customer service to the patients and providers that utilize our products. Our commitment to patient access is at the heart of our business and in the hearts and minds of our employees as we continue to grow our product portfolio.
keywords:N/AN/A
Total Funding
24
Number of Employees
$4.8M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.5M | 24 | 4% | N/A |
#2 | $2.4M | 24 | 33% | N/A |
#3 | $2.4M | 24 | -4% | N/A |
#4 | $4.9M | 24 | 4% | N/A |
#5 | $2.4M | 24 | -11% | N/A |